There is also growing evidence to support a role for myeloid cell types, especially CD16+ monocytes, in other autoimmune diseases, including in systemic lupus erythematosus (SLE) (43), another IFN-mediated disease closely related to JDM. This evidence concerns the gene FCGR3A and autoimmune disease.